Jessica Fleming

Affiliate Assistant Professor, Epidemiology



PhD Epidemiology, University of Washington, 2009
MSc Tropical Public Health, Harvard University, 1998
BS Biology, Wake Forest University, 1990



2001 Westlake Avenue, Suite 200
PO Box 900922
Seattle, WA 98109
View Website »


Jessica Fleming is a Product Development Director and the Maternal Immunization Delivery Lead in the Policy, Access and Introduction program within PATH’s Center for Vaccine Introduction and Access. With over twenty five years of experience working in international public health, she provides public health leadership in evaluating the impact of vaccines and health technologies appropriate for low resource settings and generating evidence to assist countries in preparing for new vaccine introduction. Dr. Fleming currently leads the Advancing Maternal Immunization (AMI) collaboration that enables efficient, well-informed decisions around the introduction of maternal immunizations in low- and middle-income countries, with a special emphasis on maternal vaccines for respiratory syncytial virus. She leads formative research on maternal vaccine decision-making and acceptance. Her work includes conducting clinical studies to quantify the impact of vaccines and improve their performance in low-income populations and contributing to global guidance on the use of safe injection technologies and waste management. Before joining PATH in 2003, Dr. Fleming lived and worked in a number of complex emergency and humanitarian relief settings in Africa and Asia. Dr. Fleming holds a Doctorate of Philosophy in epidemiology from the University of Washington and a Master of Science in tropical public health from the Harvard School of Public Health with a concentration in infectious disease epidemiology and international health. She is an affiliate assistant professor in the Epidemiology Department at the University of Washington.

Research Interests

Maternal immunization, Vaccine policy making; Vaccine evaluation; increasing access to health technologies in low resource settings

Recent Publications (PubMed)

Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.
JCO Precis Oncol 5():
Fleming JL, Pugh SL, Fisher BJ, Lesser GJ, Macdonald DR, Bell EH, McElroy JP, Becker AP, Timmers CD, Aldape KD, Rogers CL, Doyle TJ, Werner-Wasik M, Bahary JP, Yu HM, D'Souza DP, Laack NN, Sneed PK, Kwok Y, Won M, Mehta MP, Chakravarti A

Faculty Perceptions of the Exercise Science Student Learning Experience During the Coronavirus Pandemic.
(2021 Sep 2)
Adv Physiol Educ
Caputo JL, Mel AE, Stenson MC, Fleming JK, Johnson SL, Clark Spillios KE

Magnetic sensitivity of cryptochrome 4 from a migratory songbird.
(2021 Jun)
Nature 594(7864): 535-540
Xu J, Jarocha LE, Zollitsch T, Konowalczyk M, Henbest KB, Richert S, Golesworthy MJ, Schmidt J, Déjean V, Sowood DJC, Bassetto M, Luo J, Walton JR, Fleming J, Wei Y, Pitcher TL, Moise G, Herrmann M, Yin H, Wu H, Bartölke R, Käsehagen SJ, Horst S, Dautaj G, Murton PDF, Gehrckens AS, Chelliah Y, Takahashi JS, Koch KW, Weber S, Solov'yov IA, Xie C, Mackenzie SR, Timmel CR, Mouritsen H, Hore PJ

Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective.
(2021 Mar 24)
Hum Vaccin Immunother
Khan S, Fleming JA, Engmann CM

Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients.
(2020 Nov 23)
J Pediatr Hematol Oncol
Graham RT, Bell EH, Webb A, Zhao Y, Timmers C, Fleming JL, Sells BE, Robison NJ, Palmer JD, Finlay JL, Chakravarti A

Show complete publication list

In the News

No news articles at this time.